RhumbLine Advisers’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$384K Buy
101,986
+12,127
+13% +$45.7K ﹤0.01% 2848
2025
Q1
$407K Sell
89,859
-582
-0.6% -$2.64K ﹤0.01% 2704
2024
Q4
$639K Buy
90,441
+1,042
+1% +$7.37K ﹤0.01% 2507
2024
Q3
$728K Sell
89,399
-1,712
-2% -$13.9K ﹤0.01% 2453
2024
Q2
$582K Buy
91,111
+7,589
+9% +$48.5K ﹤0.01% 2562
2024
Q1
$629K Buy
83,522
+1,643
+2% +$12.4K ﹤0.01% 2521
2023
Q4
$758K Buy
81,879
+23
+0% +$213 ﹤0.01% 2421
2023
Q3
$828K Buy
81,856
+3,865
+5% +$39.1K ﹤0.01% 2313
2023
Q2
$975K Sell
77,991
-9,618
-11% -$120K ﹤0.01% 2304
2023
Q1
$1.02M Sell
87,609
-13,263
-13% -$155K ﹤0.01% 2108
2022
Q4
$1.07M Buy
100,872
+18,680
+23% +$199K ﹤0.01% 2096
2022
Q3
$797K Buy
82,192
+5,330
+7% +$51.7K ﹤0.01% 2265
2022
Q2
$1.11M Buy
76,862
+23,673
+45% +$343K ﹤0.01% 2085
2022
Q1
$1.39M Buy
53,189
+4,094
+8% +$107K ﹤0.01% 1992
2021
Q4
$1.95M Buy
49,095
+409
+0.8% +$16.2K ﹤0.01% 1901
2021
Q3
$2.44M Buy
48,686
+5,070
+12% +$254K ﹤0.01% 1792
2021
Q2
$2.42M Buy
43,616
+7,133
+20% +$396K ﹤0.01% 1854
2021
Q1
$1.71M Sell
36,483
-3,837
-10% -$179K ﹤0.01% 1980
2020
Q4
$1.76M Buy
40,320
+982
+2% +$42.7K ﹤0.01% 1912
2020
Q3
$1.44M Sell
39,338
-5,110
-11% -$187K ﹤0.01% 1848
2020
Q2
$1.3M Buy
44,448
+21,423
+93% +$625K ﹤0.01% 1937
2020
Q1
$602K Buy
23,025
+15,418
+203% +$403K ﹤0.01% 2099
2019
Q4
$264K Buy
7,607
+261
+4% +$9.06K ﹤0.01% 2651
2019
Q3
$232K Buy
+7,346
New +$232K ﹤0.01% 2692